Acute Aortic Disease.. - Index of

More documents

Recommendations

Info

Contents xvii Section V: Litigation in Aortic Aneurysm Disease 18. Legal Considerations in Acute Aortic Diseases . . . . . . . . . . . . . . . . . . . 331 John A. Elefteriades Section VI: Prospects for the Future 19. Future Prospects: Molecular Diagnosis, Enhanced Imaging, Molecular-Based Conventional Drugs, and Gene Therapy. . . . . . . . 347 John A. Elefteriades Section VII: Synthesis 20. The Key Lessons of This Book—In a Nutshell. . . . . . . . . . . . . . . . . . 353 John A. Elefteriades Index . . . . 361
Page 2 and 3: Acute Aortic Disease
Page 4 and 5: 15. Heart Failure: Basic Science an
Page 6: 52. Clinical, Interventional, and I
Page 9 and 10: Informa Healthcare USA, Inc. 270 Ma
Page 12 and 13: Introduction Informa Healthcare has
Page 14 and 15: Foreword There is no disease more c
Page 16 and 17: Preface Over 100 years ago, the gre
Page 18: Preface xi Some distinguishing feat
Page 21 and 22: xiv Acknowledgments Above all, than
Page 23: xvi Contents 6. Genetic Basis of Th
Page 27 and 28: xx Contributors John A. Elefteriade
Page 30 and 31: SECTION I: THE CLINICAL ENTITIES 1
Page 32 and 33: Classification of Aortic Dissection
Page 58 and 59: SECTION II: IMAGING AND DIAGNOSIS 2
Page 60 and 61: Symptoms and Signs of Acute Aortic
Page 68 and 69: 3 Imaging of Aneurysms and Dissecti
Page 70 and 71: Imaging of Aneurysms and Dissection
Page 72 and 73: Imaging of Aneurysms and Dissection
Page 74 and 75:
Imaging of Aneurysms and Dissection
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
4 Putting It All Together: Symptoms
Page 98 and 99:
Putting It All Together: Symptoms,
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
Page 106 and 107:
Page 108 and 109:
Page 110 and 111:
Page 112 and 113:
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
SECTION III: THE BIOLOGY OF ACUTE A
Page 120 and 121:
Epidemiology: Incidence, Prevalence
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
INTRODUCTION 6 Genetic Basis of Tho
Page 130 and 131:
Genetic Basis of Thoracic Aortic An
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145:
Page 146 and 147:
Page 148 and 149:
Page 150 and 151:
Page 152 and 153:
Page 154 and 155:
7 Mechanical Properties of the Aort
Page 156 and 157:
Mechanical Properties of the Aorta
Page 158:
Mechanical Properties of the Aorta
Page 161 and 162:
132 Botta et al. Figure 1 (See colo
Page 163 and 164:
134 Botta et al. (A) 2.5 2 1.5 1 0.
Page 165 and 166:
136 Botta et al. Table 2 Important
Page 167 and 168:
138 Botta et al. management that wa
Page 169 and 170:
140 Botta et al. 3. Johansson G, Ma
Page 171 and 172:
142 Botta et al. 42. Curci JA, Petr
Page 173 and 174:
144 Botta et al. 75. Tang PC, Coady
Page 175 and 176:
146 Botta et al. DISCUSSION AND COM
Page 177 and 178:
148 Botta et al. INFLAMMATORY CELL
Page 179 and 180:
150 Botta et al. Outward Vascular R
Page 181 and 182:
152 Botta et al. The Role of Fibril
Page 183 and 184:
154 Botta et al. Wall stress (kPa)
Page 185 and 186:
156 Botta et al. 10. McMillan WD, P
Page 187 and 188:
158 Botta et al. 46. Davies RR, Gol
Page 189 and 190:
160 Botta et al. 79. Vammen S, Lind
Page 191 and 192:
162 Elefteriades Table 1 Relationsh
Page 193 and 194:
164 Elefteriades confirmation (radi
Page 195 and 196:
166 Elefteriades BP (mmHg) 300 200
Page 197 and 198:
168 Elefteriades DISCUSSION AND COM
Page 199 and 200:
170 Elefteriades 65/90 (72.2%) Repo
Page 201 and 202:
172 Elefteriades DISCUSSION AND COM
Page 203 and 204:
174 Coady and Elefteriades Yale Uni
Page 205 and 206:
176 Coady and Elefteriades Aneurysm
Page 207 and 208:
178 Coady and Elefteriades The inte
Page 209 and 210:
180 Coady and Elefteriades aneurysm
Page 211 and 212:
182 Coady and Elefteriades Growth (
Page 213 and 214:
184 Coady and Elefteriades Smoking
Page 215 and 216:
186 Coady and Elefteriades Figure 7
Page 217 and 218:
188 Coady and Elefteriades Table 3
Page 219 and 220:
190 Coady and Elefteriades Figure 1
Page 221 and 222:
192 Coady and Elefteriades another
Page 223 and 224:
194 Coady and Elefteriades 35. Davi
Page 225 and 226:
196 Coady and Elefteriades family m
Page 227 and 228:
198 Coady and Elefteriades Number o
Page 229 and 230:
200 Coady and Elefteriades for 6 cm
Page 231 and 232:
202 Coady and Elefteriades There is
Page 234 and 235:
13 Treatment of Ruptured Aortic Ane
Page 236 and 237:
Treatment of Ruptured Aortic Aneury
Page 238 and 239:
Page 240 and 241:
Page 242 and 243:
Page 244 and 245:
Page 246 and 247:
Page 248 and 249:
Page 250 and 251:
Page 252 and 253:
Page 254 and 255:
Page 256:
Page 259 and 260:
230 Sanz et al. will summarize curr
Page 261 and 262:
232 Sanz et al. also decrease wall
Page 263 and 264:
234 Sanz et al. Figure 2 In the aor
Page 265 and 266:
236 Sanz et al. Hydralazin, a direc
Page 267 and 268:
238 Sanz et al. Figure 6 Schematic
Page 269 and 270:
240 Sanz et al. Table 1 Pharmacolog
Page 271 and 272:
242 Sanz et al. dissection, althoug
Page 273 and 274:
244 Sanz et al. REFERENCES 1. Niena
Page 275 and 276:
246 Sanz et al. 41. Hirst AE Jr, Jo
Page 277 and 278:
248 Sanz et al. 83. Schulte-Sasse U
Page 280 and 281:
15 Surgical Procedures: A Primer Jo
Page 282 and 283:
Surgical Procedures: A Primer 253 s
Page 284 and 285:
Surgical Procedures: A Primer 255 T
Page 286 and 287:
Surgical Procedures: A Primer 257 F
Page 288 and 289:
Surgical Procedures: A Primer 259 d
Page 290 and 291:
Page 292 and 293:
Page 294 and 295:
Page 296 and 297:
Surgical Procedures: A Primer 267 1
Page 298 and 299:
16 Endovascular Thoracic Aortic Ste
Page 300 and 301:
Endovascular Thoracic Aortic Stent
Page 302 and 303:
Page 304 and 305:
Page 306 and 307:
Page 308 and 309:
Page 310 and 311:
Page 312 and 313:
Page 314 and 315:
Table 4 Meta-Analysis of Tevar for
Page 316 and 317:
Page 318 and 319:
Page 320 and 321:
Page 322 and 323:
Page 324 and 325:
Page 326 and 327:
Page 328 and 329:
Page 330 and 331:
Page 332 and 333:
Page 334 and 335:
Page 336 and 337:
Page 338 and 339:
17 Long-Term Suppressive Therapy: C
Page 340 and 341:
Long-Term Suppressive Therapy 311 M
Page 342 and 343:
Long-Term Suppressive Therapy 313 T
Page 344 and 345:
Long-Term Suppressive Therapy 315 I
Page 346 and 347:
Long-Term Suppressive Therapy 317 I
Page 348 and 349:
Long-Term Suppressive Therapy 319 i
Page 350 and 351:
Long-Term Suppressive Therapy 321 e
Page 352 and 353:
Long-Term Suppressive Therapy 323 1
Page 354 and 355:
Page 356 and 357:
Page 358 and 359:
Page 360 and 361:
SECTION V: LITIGATION IN AORTIC ANE
Page 362 and 363:
Legal Considerations in Acute Aorti
Page 364 and 365:
Page 366 and 367:
Page 368 and 369:
Page 370 and 371:
Page 372 and 373:
Page 374 and 375:
Page 376 and 377:
SECTION VI: PROSPECTS FOR THE FUTUR
Page 378 and 379:
Future Prospects 349 1 0 1 Y: [PCA
Page 380:
Future Prospects 351 GENE-DIRECTED
Page 383 and 384:
354 Elefteriades Table 1 A Summary
Page 385 and 386:
Page 387 and 388:
Page 390 and 391:
AAA. See Abdominal aortic aneurysm
Page 392 and 393:
Index 363 [Aortic dissection imagin
Page 394 and 395:
Index 365 [Imaging] chest X-ray, 40
Page 396 and 397:
Index 367 [Ruptured aortic aneurysm
Page 398 and 399:
Figure 2 (from Preface—see text p
Page 400 and 401:
Figure 6.10 A potential molecular p
Page 402 and 403:
Figure 9.1 Histology of aortic wall
Page 404 and 405:
Number of Patients 25 20 15 10 5 0
show all

Acute Aortic Disease.. - Index of

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?